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Post-translational modiﬁcation by the ubiquitin-like
protein SUMO is often regulated by cellular signals
that restrict the modiﬁcation to appropriate situations.
Nevertheless, many SUMO-speciﬁc ligases do not exhibit
much target speciﬁcity, and—compared with the diversity
of sumoylation substrates—their number is limited. This
raises the question of how SUMO conjugation is controlled
in vivo. We report here an unexpected mechanism by
which sumoylation of the replication clamp protein,
PCNA, from budding yeast is effectively coupled to
S phase. We ﬁnd that loading of PCNA onto DNA is a
prerequisite for sumoylation in vivo and greatly stimulates
modiﬁcation in vitro. To our surprise, however, DNA
binding by the ligase Siz1, responsible for PCNA sumoyla-
tion, is not strictly required. Instead, the stimulatory effect
of DNA on conjugation is mainly attributable to DNA
binding of PCNA itself. These ﬁndings imply a change in
the properties of PCNA upon loading that enhances its
capacity to be sumoylated.
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Introduction
Through its reversible attachment to intracellular proteins the
small ubiquitin-related modiﬁer SUMO controls numerous
biological processes, ranging from nucleo-cytoplasmic trans-
port to the regulation of transcription and the maintenance of
genome stability (Kerscher et al, 2006; Geiss-Friedlander and
Melchior, 2007). Modiﬁcation by SUMO follows a mechanism
closely related to that used by the ubiquitin system: the
modiﬁer’s carboxy terminus is activated by a dedicated
activating enzyme (E1), transferred to a conjugating enzyme
(E2) and linked to a lysine residue of the substrate protein
with the aid of a ligase (E3) that confers selectivity to the
reaction. In the SUMO system, however, the single E2, Ubc9,
often participates directly in substrate recognition, and some
SUMO-speciﬁc E3s, such as mammalian RanBP2, stimulate
the conjugation reaction in a substrate-independent manner
by aligning the SUMO thioester on the Ubc9 active site in a
conformation favourable for attack by an incoming lysine
(Reverter and Lima, 2005). As a consequence, in vitro su-
moylation reactions tend to be highly promiscuous, and even
in vivo many substrates can be sumoylated by more than one
E3 (Reindle et al, 2006). Selectivity and spatio-temporal
control over the modiﬁcation can sometimes be attributed
to signalling cascades resulting in the phosphorylation of the
E3 or the substrate, but more often the dynamic regulation of
sumoylation is poorly understood (Guo et al, 2007).
In eukaryotic cells, post-translational modiﬁcations of the
replicative sliding clamp PCNA control the processing of
replication intermediates (Ulrich, 2005). In response to
DNA damage, ubiquitylation of PCNA promotes the bypass
of replication-blocking lesions (Hoege et al, 2002; Stelter and
Ulrich, 2003; Kannouche et al, 2004). In budding yeast, PCNA
(encoded by POL30) is also subject to damage-independent
sumoylation during S phase, which enhances its afﬁnity for
an antirecombinogenic helicase, Srs2 (Papouli et al, 2005;
Pfander et al, 2005). Recruitment of Srs2 by the modiﬁed
clamp prevents unscheduled recombination events during
replication. When progression of replication forks is stalled
by DNA damage, Srs2 thus inhibits resolution by homologous
recombination and allows damage bypass via the ubiquitin-
dependent pathway. Sumoylation of PCNA occurs on two
lysines, predominantly on K164 and to a lesser extent on
K127. Modiﬁcation at K164 in vivo and in vitro requires the
E3 Siz1, but Siz1 also stimulates non-selective sumoylation at
K127 and the formation of poly-SUMO chains on PCNA
(Hoege et al, 2002; Stelter and Ulrich, 2003; Windecker and
Ulrich, 2008). During most of the cell cycle, Siz1 is nuclear,
with the exception of G2/M phase, when the E3 associates
with the bud neck and participates in septin sumoylation
(Johnson and Gupta, 2001; Takahashi et al, 2001). A con-
served SAP domain, which often binds DNA in other proteins
(Okubo et al, 2004; Notenboom et al, 2007), determines
nuclear localisation or retention (Takahashi and Kikuchi,
2005) and was found to be required for PCNA modiﬁcation
(Reindle et al, 2006). SUMO is removed from PCNA by the
isopeptidase Ulp1, which associates with nuclear pore com-
plexes throughout the cell cycle (Li and Hochstrasser, 1999;
Panse et al, 2003; Stelter and Ulrich, 2003).
Under physiological conditions, sumoylation of PCNA is
limited to S phase, but it is unclear how this is controlled.
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2422We have therefore investigated the signals required for
Siz1-dependent modiﬁcation of PCNA in vivo. To our sur-
prise, we found that SUMO conjugation to PCNA is governed
less by the cognate enzymes than by the properties of the
clamp itself, in particular its association with DNA. This
mechanism of PCNA modiﬁcation is accurately reproduced
by a recombinant in vitro system and suggests a substrate-
induced control over sumoylation.
Results
PCNA sumoylation is controlled by conjugation and
de-conjugation
To understand whether regulation of conjugation by Siz1 or
of de-conjugation by Ulp1 was primarily responsible for the
restriction of PCNA sumoylation to S phase, we analysed the
cell cycle dependence of the modiﬁcation in the relevant
mutants (Figure 1A and B). Synchronised cultures of ulp1
ts
cells initiated sumoylation in S phase, but due to the slower
cell cycle progression, the modiﬁcation persisted throughout
the experiment. The marked upregulation of sumoylation
upon entry into S phase even under conditions where de-
conjugation is compromised suggested that the cell cycle
inﬂuences the conjugation reaction. As expected, sumoyla-
tion at K164 was abolished in the siz1 mutant. Surprisingly,
however, sumoylation at K127 still ﬂuctuated with the cell
cycle in this mutant, indicating that Siz1 alone cannot be
responsible for upregulating PCNA sumoylation. To assess
whether modiﬁcation at K127 was mediated solely by Ubc9
or depended on a second E3, we deleted SIZ2 in addition to
SIZ1, and now conjugation was completely abolished.
Therefore, S phase-speciﬁc sumoylation of PCNA is not
strictly dependent on its cognate E3, Siz1, but can also be
performed by the closely related Siz2 enzyme, albeit with
lower efﬁciency and on a different lysine.
These data indicate that both conjugation and de-conjuga-
tion contribute to limiting PCNA sumoylation to S phase.
However, the cell cycle-dependent ﬂuctuation of the modiﬁ-
Figure 1 Cell cycle- and DNA damage-dependent sumoylation of PCNA. (A)
HisPOL30 cells of the indicated genotypes were synchronised in G1
and released into the cell cycle. Samples were collected at the indicated times and analysed by Ni-NTA afﬁnity chromatogaphy under
denaturing conditions, followed by western blotting with PCNA-speciﬁc antibody. Asynchronous cultures (AS) were analysed in parallel.
(B) Cell cycle proﬁles of the cultures shown in (A), determined by ﬂow cytometry. (C) Lethal amounts of DNA damage cause PCNA hyper-
sumoylation in WT, but not in pol30-52 cells. Cultures were arrested in G1, S or G2 phase or left asynchronous (AS) and treated where indicated
with 0.3% methyl methanesulphonate (MMS) for 90min. In the right-hand panel, both the WTand the pol30-52 strain (52) were treated during
exponential growth. Total cell extracts prepared under denaturing conditions were analysed by western blotting using PCNA-speciﬁc antibody.
The asterisk indicates a cross-reacting band visible with some batches of the antibody. (D) DNA damage leads to chromatin association of
PCNA outside of S phase. G1 and S phase-arrested cells were treated with 0.3% MMS where indicated. Whole cell extracts (WCEs) were
prepared by enzymatic lysis, separated into soluble and chromatin-associated fractions and analysed by western blotting for the presence of
PCNA. Phosphoglycerate kinase (PGK) and histone H3 served as controls for soluble and chromatin-associated proteins. Arrests were
conﬁrmed by ﬂow cytometry (FACS).
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respective conjugating and de-conjugating enzymes in the
nucleus: ﬁrst, Siz2—unlike Siz1—remains nuclear in G2
(Takahashi et al, 2003), yet Siz2-dependent sumoylation is
lost at this time in siz1 mutants. Second, PCNA is not
sumoylated in G1 despite its colocalisation with Siz1 and
Siz2 in the nucleus. Therefore, selective modiﬁcation in
S phase appears to require cell cycle-dependent changes in
either enzyme activities or substrate properties.
PCNA sumoylation in vivo correlates with its loading
onto DNA
In response to lethal concentrations of the alkylating agent
methyl methanesulphonate (MMS), PCNA is strongly sumoy-
lated in a Siz1-dependent manner (Hoege et al, 2002;
Windecker and Ulrich, 2008). We found that this reaction
was independent of the cell cycle stage (Figure 1C). Hence,
given the appropriate signal, sumoylation of PCNA is not
limited to S phase. We reasoned that the extraordinary levels
of DNA damage inﬂicted by this treatment would likely cause
an enhanced engagement of PCNA in repair activities and
therefore a signiﬁcant association with DNA even outside of S
phase. Indeed, chromatin-binding assays after 0.3% MMS
treatment revealed strongly elevated amounts of PCNA in the
chromatin-bound fraction in an S phase-independent manner
(Figure 1D). The observed correlation between PCNA hyper-
sumoylation and chromatin association therefore suggested
that loading onto DNA might exert an effect as a signal for
PCNA sumoylation in undamaged cells as well. This notion
was also supported by the sumoylation defect of the PCNA
mutant encoded by the pol30-52 allele (Figure 1C), which is
known for poor loading onto DNA due to reduced trimer
stability (Ayyagari et al, 1995).
If loading were indeed a prerequisite for sumoylation,
preventing PCNA association with DNA during S phase
should in turn result in a failure to be modiﬁed. We therefore
examined PCNA sumoylation in a temperature-sensitive
cdc7
ts mutant. CDC7 encodes an essential protein kinase
required for the ﬁring of replication origins (Hartwell,
1973). Upon release from G1 arrest at the restrictive tempera-
Figure 2 PCNA sumoylation during S phase requires active replication forks. (A) WT and cdc7
ts cells bearing the
HisPOL30 allele, grown at
251C, were synchronised in G1 and either kept at 251C or shifted to 371C for 90min before releasing them into the cell cycle at the indicated
temperatures. Samples were taken before release (G1) and in mid-S phase (S) according to the budding pattern and Clb2 levels (30min for WT
at 251C and cdc7
ts at both temperatures, 15min for WTat 371C). PCNA sumoylation was detected as described in Figure 1, Clb2 and PGK were
detected in total cell extracts, and the DNA content was monitored by ﬂow cytometry (FACS; dashed line: G1 arrest; solid line: after release).
(B) Subcellular distribution of Siz1 in WTand cdc7
ts cells. Both strains expressing GFP-tagged Siz1 were synchronised in G1 and released into
the cell cycle at 25 or 371C as in (A). Samples were taken at 20-min intervals and analysed by ﬂuorescence microscopy for Siz1–GFP and DNA
(DAPI). Representative cells are shown as overlays of ﬂuorescence with interference contrast images. (C) Cdc7 kinase is not required for PCNA
sumoylation. Modiﬁcation of
HisPCNAwas analysed in asynchronous cultures of bob1 and bob1 cdc7D mutants. The bob1 mutation affects the
MCM5 gene and renders CDC7 non-essential.
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ts cells do not initiate DNA replication, although
budding pattern and cyclin-dependent kinase activities all
resemble a passage through the cell cycle. We found that
under these conditions, PCNA was not sumoylated
(Figure 2A) at a time when the levels of the mitotic cyclin
Clb2 (Figure 2A) and the budding pattern (Figure 2B) in-
dicated an S phase-like state. Siz1 was nuclear at this stage
and accumulated at the bud neck only in G2/M phase
(Figure 2B), when cdc7
ts cells were arrested due to a failure
to undergo mitosis with an unreplicated genome. We ex-
cluded the formal possibility that the kinase activity of Cdc7
was required for PCNA sumoylation by conﬁrming the mod-
iﬁcation in a cdc7 deletion mutant, using a strain background
in which CDC7 was rendered non-essential by a mutation in
MCM5, a subunit of the replicative helicase (Hardy et al,
1997) (Figure 2C). Therefore, ongoing DNA replication rather
than a particular cell cycle regulatory programme appears to
bring about PCNA sumoylation, strongly suggesting that the
clamp is modiﬁed only when it encircles DNA.
PCNA loading stimulates sumoylation in vitro
We have previously demonstrated Siz1-dependent in vitro
sumoylation of PCNA in the absence of DNA (Windecker and
Ulrich, 2008), but if clamp loading were the main prerequisite
for modiﬁcation in vivo, association with DNA would also
stimulate the reaction in vitro. Loading of PCNA is ATP
dependent and requires replication factor C (RFC), which
opens the PCNA ring and positions the clamp around the
DNA at nicks within double-stranded (ds)DNA or 30 junctions
of a primer terminus and single-stranded (ss)DNA (Majka
and Burgers, 2004). After loading, PCNA can move freely on
DNA, but cannot slide off a circular structure. We therefore
examined the effect of puriﬁed RFC in the presence of multi-
ply primed circular ssDNA at substrate concentrations that
yielded barely detectable levels of Siz1-dependent modiﬁca-
tion in the absence of DNA. As shown in Figure 3A, addition
of DNA and RFC strongly stimulated the reaction.
Importantly, neither RFC nor DNA alone enhanced SUMO
conjugation, indicating that clamp loading rather than ring
opening or the mere presence of DNA was important for
stimulation. The same effect was observed with a linear
biotinylated DNA containing a 30 junction, provided that its
ends were blocked by the addition of streptavidin
(Figure 3B). As RFC-dependent loading occurs in the pre-
sence or absence of streptavidin, this result implies that a
stable DNA-bound state rather than the process of loading
determines the efﬁciency of PCNA sumoylation. Consistent
with the loading defect, modiﬁcation of the mutant protein
encoded by pol30-52 was not stimulated by RFC (Figure 3C),
whereas DNA-independent sumoylation at higher protein
concentration proceeded with an efﬁciency comparable to
the WT (Figure 3D). This again indicates that PCNA needs to
encircle DNA as a trimer to be sumoylated efﬁciently.
Siz1 binds dsDNA by means of a SAP domain
Given that Siz1 contains a SAP domain required for PCNA
sumoylation (Reindle et al, 2006), it appeared likely that the
enhanced modiﬁcation of loaded PCNA was attributable to
DNA binding of the E3. We therefore asked whether budding
yeast Siz1, similar to other members of the PIAS family, was
indeed a DNA-binding protein. Recombinant full-length Siz1
was efﬁciently retained on a biotinylated 76-bp fragment of
dsDNA (Figure 4A and B). Its afﬁnity for a 25-bp dsDNA was
signiﬁcantly reduced, and no signal was detected with a
15-bp fragment. Interestingly, binding was strictly limited to
dsDNA. Siz1 did not exhibit enhanced afﬁnity for ss–dsDNA
junctions or tailed structures when compared with linear
dsDNA (Figure 4C), suggesting that the protein primarily
recognises ordinary dsDNA. To conﬁrm the importance of
the SAP domain for DNA binding, we constructed two Siz1
mutants: SAP*, by mutating three conserved residues within
the SAP domain (G55A/K57A/L60A), and SAPD, by deleting
residues 34–68. The puriﬁed proteins had no detectable
afﬁnity for the 76-bp dsDNA (Figure 4D), indicating that
the SAP domain is required for DNA binding.
The Siz1 SAP domain is dispensable for PCNA
sumoylation
Consistent with previous observations (Reindle et al, 2006),
deletion of the SAP domain resulted in loss of sumoylation at
K164 in vivo, whereas the SAP* mutation had a partial effect
(Figure 5A). This pattern was mirrored in a genetic assay
based on suppression of the DNA damage sensitivity of rad18
mutants by loss of SIZ1 function (Stelter and Ulrich, 2003)
(Figure 5B). The PCNA sumoylation defect of siz1(SAPD) had
previously been attributed to a defect in nuclear localisation
or retention, possibly due to a lack of Siz1 association with
Figure 3 PCNA sumoylation in vitro is stimulated by loading onto
DNA. (A) In vitro sumoylation assays were performed with recom-
binant Ubc9 and SUMO in the presence or absence of PCNA, E1,
RFC, Siz1 and circular, multiply primed ssDNA as indicated.
Products were analysed by western blotting with PCNA-speciﬁc
antibody. (B) In vitro sumoylation reactions were carried out with
the complete set of proteins as in (A), but in the presence or absence
of streptavidin (SA) and two different linear DNA structures (I and
II) derivatised with biotin on both termini. (C) WT
HisPCNA and the
trimerisation-deﬁcient protein encoded by the pol30-52 allele (52)
were compared in sumoylation assays containing E1, Ubc9, Siz1,
SUMO and circular primed ssDNA in the presence or absence of
RFC. (D) Ubc9- and Siz1-dependent in vitro sumoylation of WTand
mutant (52)
HisPCNA in the absence of DNA.
HisPCNA was used at
3mM (compared with 50nM in A–C).
SUMO modiﬁcation of PCNA is controlled by DNA
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analysis of the mutated Siz1 proteins marked with a 9myc-
epitope revealed strongly reduced signals for SAP* and in
particular for SAPD in total cell extracts, implying that the
lack of activity towards PCNA in vivo might be due to
insufﬁcient protein rather than ineffective nuclear localisa-
tion or defective DNA binding (Figure 5C). In fact, over-
expression of the mutants from a galactose-inducible
promoter completely rescued the sumoylation defect of
SAP* and SAPD (Figure 5D) and fully restored the damage
sensitivity of rad18 cells (Figure 5E). To exclude the
possibility that overproduction of the mutant Siz1 proteins
compensated for a loss in activity, we placed the SAPD allele
under control of the copper-inducible CUP1 promoter, which
resulted in protein levels comparable to WT Siz1 under
control of its native promoter (Figure 5F). In the presence
of copper sulphate, this construct almost completely rescued
the phenotype of the siz1 deletion with respect to DNA
damage sensitivity (Figure 5G) and PCNA sumoylation
(Figure 5H). This indicates that DNA binding of Siz1
might not be a prerequisite for efﬁcient modiﬁcation of
PCNA in vivo.
Loading onto DNA changes the properties of PCNA
as a sumoylation target
To directly compare the activities of the mutant proteins
towards PCNA, we analysed their effects on PCNA sumoyla-
tion in vitro at a range of concentrations. In the absence of
DNA, the activities of SAP* and SAPD were slightly lower
than those of WT Siz1, and selectivity for K164 was some-
what reduced, possibly indicating some destabilisation of the
mutant proteins (Figure 6A). Towards loaded PCNA, both
mutants were less active than the WT protein; in particular,
formation of poly-SUMO chains was reduced compared with
the WT (Figure 6B). Nevertheless, conjugation at K164 by the
Siz1 mutants was strongly stimulated by RFC-dependent
PCNA loading, indicating that DNA binding of the E3 is not
primarily responsible for the effect of PCNA loading on
conjugation efﬁciency. Similar results were obtained with a
truncated construct, Siz1(1–508), and its corresponding SAP
domain mutants, although the differences in DNA-indepen-
dent activities between the WTand the SAP domain mutants
were even more pronounced (see Supplementary Figure S1).
The notion that even Siz1 mutants defective in DNA
binding preferentially modify PCNAwhen the clamp encircles
DNA raised the question of whether stimulation of the
reaction could be ascribed primarily to DNA-induced changes
in the substrate rather than a proximity effect mediated by the
binding of substrate and E3 to a common stretch of DNA. We
therefore examined whether PCNA modiﬁcation in the ab-
sence of Siz1 was also inﬂuenced by DNA. Figure 6C shows
in vitro sumoylation of PCNA in the presence of primed DNA
as before, but at higher Ubc9 concentrations. Surprisingly,
RFC stimulated Ubc9-dependent sumoylation at K127 even in
Figure 4 The Siz1 SAP domain is required for DNA binding. (A)
Siz1 binds to dsDNA, but not ssDNA. Equimolar amounts of
biotinylated DNA fragments of the indicated lengths were immobi-
lised on streptavidin Sepharose, and increasing amounts
of
GSTSiz1
FLAGHis were added. Material retained after washing was
analysed by western blotting with anti-FLAG antibody. (B) Binding
to a 76-nt fragment of ssDNA or dsDNA was analysed as above in
the presence of 1mM EDTA. (C) Equimolar amounts of the indi-
cated DNA structures were immobilised on streptavidin Sepharose,
and Siz1 binding was analysed as above. (D) Mutation or deletion of
the Siz1 SAP domain results in loss of DNA binding. Equal amounts
of Siz1 WT, SAP* and SAPD were analysed on 76mer dsDNA
as above.
Figure 5 The Siz1 SAP domain is dispensable for PCNA sumoylation in vivo.( A) Mutation or deletion of the SAP domain appears to result in
partial or complete loss of PCNA sumoylation in vivo. Deletion mutants of siz1 were complemented with integrative plasmids bearing WT,
SAP* or SAPD alleles of SIZ1 or empty vector ( ), and modiﬁed PCNA was detected in denaturing extracts as described in Figure 1.
(B) Mutation or deletion of the SAP domain appears to result in partial or complete loss of SIZ1 function. Sensitivities of the indicated strains to
the DNA-damaging agents, methyl methanesulphonate (MMS) and 4-nitroquinoline oxide (NQO) were monitored by growth on plates
containing the indicated concentrations of the drugs. Suppression of the damage sensitivity associated with the rad18 deletion indicates a loss
of SIZ1 function. (C) Mutation or deletion of the SAP domain results in loss of the Siz1 protein in vivo, which can be rescued by overexpression.
The indicated SIZ1 alleles were expressed from integrative plasmids under control of the SIZ1 or the galactose-inducible GAL1 promoter and
tagged C-terminally by a 9myc-epitope. An empty plasmid ( ) served as a control. Cells were grown in the presence of glucose or galactose,
and total extracts were analysed for the presence of Siz1
9myc by western blotting. Detection of PGK served as a loading control. (D)
Overexpression suppresses the sumoylation defects of the SIZ1 SAP domain mutants. The SIZ1 constructs shown in (C) were introduced into
the
HisPOL30 siz1 strain, and PCNA modiﬁcations were analysed as in Figure 1 after growth in galactose medium. (E) Overexpression of SIZ1
alleles suppresses the loss of function associated with mutation or deletion of the SAP domain. The SIZ1 constructs shown in (C) were
introduced into rad18 siz1 strains, and SIZ1 function was analysed as described for (B) on glucose or galactose plates. (F) Expression of the
siz1(SAPD) allele under control of the CUP1 promoter results in near physiological protein levels. The CUP1 promoter was induced by growth
in 100mM CuSO4, and 9myc-tagged versions of the indicated SIZ1 alleles were analysed as in (C). (G) Expression of siz1(SAPD) under control of
the CUP1 promoter suppresses the siz1 phenotype. DNA damage sensitivity assays were carried out with the indicated SIZ1 alleles in rad18 siz1
as in (B, E) in the presence or absence of 100mM CuSO4.( H) Expression of siz1(SAPD) under control of the CUP1 promoter restores PCNA
sumoylation in vivo. The indicated SIZ1 alleles were analysed in
HisPOL30 siz1 as in (A, D) in the presence or absence of 100mM CuSO4.
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we were unable to detect any physical interactions between
Ubc9 and either DNA or RFC under our experimental condi-
tions (data not shown), we consider an indirect recruitment
of Ubc9 to PCNA unlikely and favour a model in which PCNA
itself, when loaded onto DNA, becomes a better substrate for
sumoylation.
The inner surface of the PCNA ring is lined by several
conserved basic residues, which are likely to directly contact
DNA (Fukuda et al, 1995; Lau et al, 2002; Ivanov et al, 2006)
and might therefore inﬂuence the conformation of loaded
PCNA. Indeed, the respective mutants poorly stimulate poly-
merase d, although loading and sliding are not affected
(Fukuda et al, 1995; Lau et al, 2002). When we examined
SUMO modiﬁcation of PCNA is controlled by DNA
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pol30(K77A), we found signiﬁcant defects, in particular in
pol30(K20A), which affects a lysine predicted to interact with
bound DNA close to the centre of the minor groove (Ivanov
et al, 2006) (Figure 6D). Growth and cell cycle distribution of
the corresponding cultures were normal, indicating that the
defects in PCNA sumoylation were not due to replication
problems (Figure 6E). These observations are consistent with
a change in conformation and/or ﬂexibility of PCNA upon
DNA binding that is transmitted from the inner surface to the
outer rim of the clamp, where it is sensed by the sumoylation
system.
Discussion
Control of PCNA sumoylation by Siz1 and Ulp1
Our ﬁndings suggest an effective mechanism by which SUMO
conjugation can be targeted to S phase. We have shown that
the overall levels of SUMO-modiﬁed PCNA are inﬂuenced
both by Siz1-dependent conjugation and by Ulp1-mediated
de-conjugation. Yet, a cell cycle-dependent ﬂuctuation of
sumoylation is observed even when the relevant enzymes
are defective, suggesting that changes in enzyme properties
or localisation are not primarily responsible for the temporal
control of PCNA modiﬁcation. Instead, we found that sumoy-
lation of PCNA in vivo prevailed whenever the clamp was
associated with DNA. Considering that even in replicating
cells a signiﬁcant part of the cellular pool of PCNA is not
bound to DNA (Essers et al, 2005), the total extent of PCNA
sumoylation in synchronised cultures (Figure 1A) actually
suggests that a major proportion of DNA-loaded PCNA is
modiﬁed in S phase. Consistent with these observations, we
found that the efﬁciency of PCNA sumoylation in vitro is
inﬂuenced only to some degree by DNA binding of the E3, but
more importantly by the stable loading of the clamp onto
DNA. Taken together, S phase-associated sumoylation there-
fore appears to be triggered mainly by a change in the
properties of PCNA induced by RFC-dependent loading.
We cannot exclude a minor contribution of cell cycle-
dependent changes in E3 or Ulp1 activity to the regulation
of PCNA sumoylation. For example, the re-localisation of Siz1
from the nucleus to the bud neck at mitosis is likely due to its
cell cycle-regulated phosphorylation (Johnson and Gupta,
2001) and may well affect the efﬁciency of PCNA sumoylation
at that time. However, given that loading stimulates the
reaction with recombinant proteins in vitro, and loaded
PCNA can be modiﬁed outside of S phase in vivo, a change
in substrate properties is sufﬁcient to explain our observa-
tions. According to this model, Ulp1-dependent desumoyla-
tion of PCNA at the end of S phase could be induced either by
a shift in the balance between conjugation and de-conjuga-
tion upon unloading or alternatively by an enhanced
exposure of ‘soluble’ PCNA to the nuclear pore-associated
Ulp1. The regulation of PCNA modiﬁcation thus exempliﬁes
Figure 6 PCNA loading stimulates sumoylation by Siz1 SAP mutants and by Ubc9 alone. (A) Mutation or deletion of the Siz1 SAP domain has
no effect on PCNA sumoylation in the absence of DNA. In vitro sumoylation assays were performed at high substrate concentration (3mM) with
increasing amounts of Siz1 WT, SAP* or SAPD protein.
GSTSiz1
FLAGHis was detected by western blotting with anti-FLAG antibody. (B) PCNA
loading stimulates sumoylation by Siz1 SAP mutants. In vitro sumoylation assays in the presence of RFC and circular primed ssDNA were
performed at low substrate concentration (50nM) with increasing amounts of Siz1 WT, SAP* or SAPD protein (B1–40nM).
GSTSiz1
FLAGHis was
detected by western blotting with anti-FLAG antibody. (C) PCNA loading stimulates E3-independent sumoylation. In vitro sumoylation assays
in the presence of RFC and circular primed ssDNA were performed with 10-fold elevated concentration of Ubc9 (5mM). (D) PCNA mutants
whose interactions with DNA are altered exhibit reduced sumoylation. PCNA modiﬁcations in vivo were analysed in WT, pol30(K20A) and
pol30(K77A) as described in Figure 1. (E) Cell cycle distribution of the POL30 alleles shown in (D), determined by ﬂow cytometry (FACS).
SUMO modiﬁcation of PCNA is controlled by DNA
JL Parker et al
The EMBO Journal VOL 27 | NO 18 | 2008 &2008 European Molecular Biology Organization 2428how dynamic control in the SUMO system can be achieved at
the substrate level despite the limited number and selectivity
of conjugation factors.
Independent signals for PCNA sumoylation and
ubiquitylation
In analogy to the system described here, ubiquitylation of
PCNA by the E3 Rad18 was shown to be limited to the DNA-
bound form both in vivo and in vitro (Garg and Burgers, 2005;
Davies et al, 2008). In this case, recruitment of Rad18 by the
ssDNA-binding replication protein A (RPA) was found to be
required for ubiquitylation in vivo (Davies et al, 2008). In
contrast, depletion of RPA does not affect PCNA sumoylation
(Davies et al, 2008), and in vitro sumoylation of loaded PCNA
proceeds efﬁciently in the absence of RPA. Hence, although
the two modiﬁcations affect the same site on PCNA, they are
initiated in response to independent signals: whereas ubiqui-
tylation is rendered damage inducible by a dependence on the
accumulation of RPA-coated ssDNA at stalled replication
intermediates, the sumoylation enzymes react primarily to
the loading state of the clamp itself and thereby exert an effect
constitutively during S phase.
SUMO conjugation as a probe for the conformation
of PCNA
Our observations provide evidence for a conformational
change of the clamp upon loading. This concept has been
postulated based on molecular dynamics simulations (Ivanov
et al, 2006), but has not been demonstrated experimentally
due to the difﬁculties associated with analysing interactions
of a topological rather than an afﬁnity-based nature.
Interactions between PCNA and several other replication
proteins are well known to be affected by DNA. For example,
polymerase d is stimulated only by DNA-bound PCNA,
and the productive mode of interaction between PCNA
and the ﬂap endonuclease FEN-1 that occurs on DNA differs
from that observed in solution (Li et al, 1995; Jonsson et al,
1998; Gomes and Burgers, 2000). However, as both polymer-
ase d and FEN-1 are DNA-binding proteins themselves, their
stimulation by loaded PCNA might be due to their own
rearrangement on DNA rather than a conformational change
of the clamp. This is unlikely to apply to Ubc9; yet the E2 is
able to differentiate between loaded and unloaded PCNA.
Hence, the sensitivity of the SUMO conjugation system to the
loading state of PCNA demonstrates for the ﬁrst time that
contacts between the DNA and the basic inner surface of the
clamp can have an impact on residues situated on the outer
edge. Changes in the properties of PCNA may well affect its
interactions with other replication- or repair-associated pro-
teins. For example, a contribution of conformational changes
within PCNA itself to Rad18-dependent ubiquitylation cannot
be excluded until a ligase mutant deﬁcient in DNA binding is
examined. A detailed understanding of the nature of these
conformational changes will have to await the structural
characterisation of PCNA in complex with DNA.
Materials and methods
Yeast strains
Standard procedures were followed for the growth and manipula-
tion of Saccharomyces cerevisiae. Mutants ulp1
ts, siz1, rad18, cdc7
ts,
bob1 and bob1 cdc7D have been described previously (Papouli et al,
2005; Davies et al, 2008; Windecker and Ulrich, 2008). Where
required, the
HisPOL30 allele was introduced as described (Stelter
and Ulrich, 2003; Windecker and Ulrich, 2008), and
Hispol30(K20A)
and
Hispol30(K77A) were constructed analogously. SIZ2 was deleted
by replacement with a KanMX6 cassette. The pol30-52 allele was
introduced on a centromeric plasmid, pBL230-52 (Ayyagari et al,
1995), followed by disruption of endogenous POL30. The SIZ1
alleles were expressed in siz1 deletion strains from integrative
plasmids under control of the endogenous or the GAL1 or the CUP1
promoter (see below). For detection by western blotting, these
alleles were marked with a 9myc-epitope by integration of a PCR-
ampliﬁed cassette in place of the stop codon.
Plasmids
The yeast expression vector for
HisPOL30 has been described
previously (Papouli et al, 2005; Davies et al, 2008; Windecker and
Ulrich, 2008), and mutations K20A and K77A were introduced by
site-directed mutagenesis. pBL230-52 was a gift from P Burgers
(Ayyagari et al, 1995). Recombinant
HisPCNA was expressed in
Escherichia coli from pQE-30 (Windecker and Ulrich, 2008), and
mutant alleles were constructed in the same vector. pET11c
(Novagen) served for expression of recombinant untagged PCNA.
Yeast expression vector p416-Siz1-GFP was a gift from E Johnson
(Johnson and Gupta, 2001). For expression of native SIZ1 in yeast,
the open reading frame with 535bp of its upstream region was
ampliﬁed from genomic DNA and inserted into the integrative
vector YIplac211, followed by a transcriptional terminator. Mutant
alleles were constructed by PCR. The SIZ1 upstream region was
replaced by the yeast GAL1 or CUP1 promoter for galactose- or
copper-inducible expression, respectively. The E. coli expression
vector for
GSTSiz1
FLAGHis has been described (Windecker and Ulrich,
2008), and the SAP domain mutants were transferred into this
construct. An expression vector for yeast RFC was a gift from P
Burgers (Franco et al, 2005), those for recombinant
HisAos1,
Uba2
His, Ubc9
His and
HisSUMO were from E Johnson (Johnson
and Gupta, 2001).
Protein puriﬁcations
Recombinant
HisPCNA, E1 (
HisAos1/Uba2
His), Ubc9
His,
HisSUMO,
RFC and
GSTSiz1
FLAGHis were produced as previously described
(Franco et al, 2005; Windecker and Ulrich, 2008). The Siz1 SAP
domain mutants were expressed and puriﬁed by the same
procedure as the WT protein. Mutant PCNA proteins were produced
as His6-tagged constructs and puriﬁed similar to WT
HisPCNA.
Untagged PCNA was produced from the expression vector
pET11c in E. coli strain BL21-CodonPlus(DE3)-RIL (Stratagene).
The bacterial pellet from a 2l culture was re-suspended in buffer A
(25mM Tris pH 7.5, 1mM EDTA, 0.5mM DTT) containing 50mM
NaCl and CompleteTM protease inhibitors (Roche) and lysed by
sonication. All steps were carried out at 41C. The lysate was cleared
by centrifugation at 40000g for 20min and then at 150000g for
45min. Nucleic acids were removed by Polymin P precipitation,
and the lysate was subjected to HiTrap Q chromatography. PCNA-
containing fractions were dialysed into buffer A containing 40mM
NaCl and passed through a 5ml S-Sepharose column. Following
MonoQ chromatography (1ml column), PCNA-containing fractions
were pooled and applied to a Superdex 200 gel ﬁltration column
equilibrated in buffer A containing 200mM NaCl and 10% glycerol.
The puriﬁed protein was stored at  801C.
Detection of PCNA modiﬁcations in vivo
In vivo PCNA modiﬁcations were detected by denaturing Ni-NTA
afﬁnity chromatography and western blot analysis as described
previously, using PCNA- and SUMO-speciﬁc antibodies (Papouli
et al, 2005; Davies et al, 2008). After treatment with 0.3% MMS,
sumoylated PCNA was detected in total cell extracts. Cells were
arrested in G1, S or G2 phase with 10ng/ml a-factor, 100mM
hydroxyurea or 15mg/ml nocodazole for 1.5–3h, respectively. Cell
cycle stage was monitored by ﬂow cytometry. For induction of the
GAL1 promoter, cells were pre-grown in a medium containing 2%
rafﬁnose, transferred to 2% galactose medium for overnight
growth, and diluted into fresh galactose medium to obtain
exponential cultures. Induction of the CUP1 promoter was achieved
by overnight growth in 100mM CuSO4. Control cultures were
obtained analogously by transfer and dilution into glucose or
copper-free medium.
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In vitro sumoylation assays without DNA were performed as
previously described (Windecker and Ulrich, 2008). For reactions
in the presence of DNA, 10 oligonucleotides of 28–35nt length were
annealed to FX174 virion DNA (New England Biolabs) spaced
roughly equally along the sequence (DECAprimed DNA). Unless
otherwise noted, sumoylation reactions (20ml) contained 50mM
HEPES, pH 7.0, 140mM NaCl, 5mM MgCl2, 0.1mM DTT, 1mM ATP,
2.5nM DECAprimed DNA, 50nM PCNA or
HisPCNA, 30nM RFC,
200nM E1, 500nM Ubc9
His and 8mM
HisSUMO. Siz1 was added at a
ﬁnal concentration of B25nM or titrated in the range of B1–40nM
(Figure 6A and B). Reactions in the presence of linear DNA were set
up as described above, but contained 25nM biotinylated primed or
unprimed DNA, 18nM RFC and 1mM streptavidin where noted.
Reactions were incubated at 301C for 2h before being terminated by
the addition of reducing SDS loading buffer and denaturation at 951C
for 4min. Samples were analysed by western blotting using an anti-
PCNA antibody. PCNA and
HisPCNA were modiﬁed with equal
efﬁciency in these assays (data not shown).
In vitro DNA-binding assays
A DNA fragment of a given structure, consisting of either a ss 50-
biotinylated oligonucleotide or an annealed pair of oligonucleo-
tides, one of which carried a 50-biotin label, was immobilised on
streptavidin Sepharose in binding buffer (0.1mg/ml BSA, 50mM
Tris–HCl, pH 7.5, 10mM MgCl2 or 1mM EDTA, 1mM DTT, 0.05%
Triton X-100, 150mM NaCl) for 30min at room temperature. The
beads were washed three times with binding buffer before use.
Binding of Siz1 was analysed by incubation of 20ml beads
(B10pmol of DNA) with increasing amounts of
GSTSiz1
FLAGHis
(Figure 4A and B: 2 and 8pmol; Figure 4C: 2, 4, 8 and 15pmol;
Figure 4D: 4 and 12pmol) for 60min at 41C. The beads were
washed four times with binding buffer, and bound material was
eluted by denaturation in SDS loading buffer and detected by
western blotting with anti-FLAG antibody.
Chromatin-binding assays
Total cell extracts prepared by spheroplast lysis were fractionated
into soluble and chromatin-bound fractions by centrifugation
through a sucrose cushion and analysed by Western blotting as
described previously (Davies et al, 2008).
Fluorescence microscopy
WT or cdc7
ts cells harbouring p416-Siz1-GFP (Johnson and Gupta,
2001) were grown to exponential phase in galactose medium at
251C and treated as described in the legend of Figure 2. Samples
were withdrawn at 20-min intervals, and DNA was stained with
0.5mg/ml 40,6-diamidino-2-phenylindole (DAPI). Cells were ana-
lysed by ﬂuorescence microscopy on a DeltaVision SpectrisTM
system for DAPI and GFP signals. Fluorescence images were
processed and overlayed with differential interference contrast
images using the ImprovisionTM software.
Genetic analysis of SIZ1 function
Growth of yeast strains harbouring relevant SIZ1 alleles in a rad18
background was monitored on plates containing various types and
concentrations of DNA-damaging agents, using WT, rad18, siz1 and
rad18 siz1 as control strains. Loss of SIZ1 function is indicated by a
partial suppression of the damage sensitivity associated with the
rad18 deletion (Papouli et al, 2005; Windecker and Ulrich, 2008).
For analysis of GAL1-o rCUP1-inducible SIZ1 alleles, cultures were
pregrown in liquid glucose or galactose medium or in the presence
or absence of 100mM CuSO4 and analysed on plates containing the
corresponding carbon source or copper concentration.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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